ASO Visual Abstract: Immune-Adjusted Nodal Risk Classification After Neoadjuvant Immunotherapy for Resectable Head and Neck Cutaneous Squamous Cell Carcinoma
Yajing Du, Qiongqiong Yu. ASO Visual Abstract: Immune-Adjusted Nodal Risk Classification After Neoadjuvant Immunotherapy for Resectable Head and Neck Cutaneous Squamous Cell Carcinoma. // Annals of Surgical Oncology. – 2026. – DOI: 10.1245/s10434-026-20395-9. – URL: https://doi.org/10.1245/s10434-026-20395-9
Yajing Du & Qiongqiong Yu (2026). ASO Visual Abstract: Immune-Adjusted Nodal Risk Classification After Neoadjuvant Immunotherapy for Resectable Head and Neck Cutaneous Squamous Cell Carcinoma. Annals of Surgical Oncology. https://doi.org/10.1245/s10434-026-20395-9
Yajing Du and Qiongqiong Yu. “ASO Visual Abstract: Immune-Adjusted Nodal Risk Classification After Neoadjuvant Immunotherapy for Resectable Head and Neck Cutaneous Squamous Cell Carcinoma.” Annals of Surgical Oncology, 2026. doi:10.1245/s10434-026-20395-9.
@article{Du2026,
title = {ASO Visual Abstract: Immune-Adjusted Nodal Risk Classification After Neoadjuvant Immunotherapy for Resectable Head and Neck Cutaneous Squamous Cell Carcinoma},
author = {Du, Yajing and Yu, Qiongqiong},
journal = {Annals of Surgical Oncology},
year = {2026},
doi = {10.1245/s10434-026-20395-9},
url = {https://doi.org/10.1245/s10434-026-20395-9}
}